Jun‐Long Liang
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Nanoplatforms for cancer theranostics 20
- Graphene and Nanomaterials Applications 5
- Immunology 12
- Immune cells in cancer 6
- Immunotherapy and Immune Responses 5
- interferon and immune responses 4
- Co-authors
- Xian‐Zheng Zhang (24 shared papers)Xiao‐Kang Jin (16 shared papers)Qian‐Xiao Huang (13 shared papers)Wei‐Hai Chen (13 shared papers)Guo‐Feng Luo (5 shared papers)Shi‐Man Zhang (13 shared papers)Mei‐Ting Niu (6 shared papers)Chuan‐Jun Liu (4 shared papers)
- Journals
- Advanced Materials (5 papers)Biomaterials (4 papers)Nano Letters (3 papers)Nano Today (3 papers)Materials Today (2 papers)
- Partner nations
- ChinaIranNew Zealand
In The Last Decade
Jun‐Long Liang
31 papers receiving 1.2k citations
Jun‐Long Liang's Hit Papers
Peers
Comparison fields: 5 of 92
- Biomaterials 278
- Biomedical Engineering 711
- Immunology 290
- Biotechnology 76
- Materials Chemistry 289
Countries citing papers authored by Jun‐Long Liang
This map shows the geographic impact of Jun‐Long Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Long Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Long Liang more than expected).
Fields of papers citing papers by Jun‐Long Liang
This network shows the impact of papers produced by Jun‐Long Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Long Liang. The network helps show where Jun‐Long Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun‐Long Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 165 | |
| 2 | Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma Hit paper breakdown → | 2023 | 123 |
| 3 | 2023 | 108 | |
| 4 | 2016 | 103 | |
| 5 | 2023 | 96 | |
| 6 | 2023 | 67 | |
| 7 | 2018 | 60 | |
| 8 | 2023 | 47 | |
| 9 | 2019 | 43 | |
| 10 | 2023 | 40 | |
| 11 | 2024 | 34 | |
| 12 | 2020 | 34 | |
| 13 | 2024 | 25 | |
| 14 | 2023 | 24 | |
| 15 | 2023 | 24 | |
| 16 | 2019 | 23 | |
| 17 | 2020 | 21 | |
| 18 | 2024 | 19 | |
| 19 | 2022 | 18 | |
| 20 | 2024 | 14 |
About Jun‐Long Liang
Jun‐Long Liang is a scholar working on Biomedical Engineering, Immunology, Molecular Biology, Biotechnology and Materials Chemistry, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (20 papers), Cancer Research and Treatments (7 papers), Immune cells in cancer (6 papers), Graphene and Nanomaterials Applications (5 papers), Immunotherapy and Immune Responses (5 papers), interferon and immune responses (4 papers), Carbon and Quantum Dots Applications (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). The work is most often cited by research in Biomaterials (278 citations), Biomedical Engineering (711 citations), Immunology (290 citations), Biotechnology (76 citations) and Materials Chemistry (289 citations). Jun‐Long Liang has collaborated with scholars based in China, Iran and New Zealand. Frequent co-authors include Xian‐Zheng Zhang, Xiao‐Kang Jin, Qian‐Xiao Huang, Wei‐Hai Chen, Guo‐Feng Luo, Shi‐Man Zhang, Mei‐Ting Niu, Chuan‐Jun Liu, Bing Wang and Zhiwen Hu. Their work appears in journals such as Advanced Materials, Biomaterials, Nano Letters, Nano Today and Materials Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.